Question 1

Does an MRNA CFD make you a Moderna shareholder?

Accepted Answer

It does not. A CFD is a cash-settled contract referencing the listed share price. The contract gives you directional exposure, with profit or loss calculated from the price change between entry and exit, multiplied by the contract size. There is no entry on Moderna's share register, no proxy vote, no annual-report mailing, and no dividend cash payment when one exists. Settlement of any gain or loss happens in your account's base currency after conversion from USD where needed.

Question 2

How much leverage does LHFX offer on single-stock CFDs like MRNA?

Accepted Answer

The maximum leverage on US single-stock CFDs is 1:20. That headline number is misleading on a high-volatility name like Moderna, because trial-readout sessions can produce 15 to 25% gaps. At the cap, a 5% adverse move is enough to absorb your entire margin contribution. In practice, traders who survive multiple readout cycles tend to run effective leverage of around 1:4 to 1:6 and keep total MRNA exposure to a small percentage of account equity.

Question 3

What hours can you trade Moderna at LHFX?

Accepted Answer

MRNA is quotable during US regular cash-equity hours, 14:30 to 21:00 UTC, Monday to Friday, excluding US public holidays. Pre-market and after-hours sessions are not available on the CFD product. Major headlines that hit overnight, including most conference-abstract releases, are absorbed at the next regular-hours open rather than during the overnight period.

Question 4

Why is the personalised cancer programme such a big deal for the share price?

Accepted Answer

The mRNA-4157 candidate is a custom neoantigen therapy where each dose is manufactured from a biopsy of the patient's own tumour. Combined with Merck's Keytruda in adjuvant melanoma, it delivered a roughly 49% reduction in the risk of recurrence or death in a Phase 2b study. Confirmatory Phase 3 readouts in melanoma and additional tumour types are due over the coming years; the market treats these as binary repricing events for both the cancer programme and, by extension, the broader platform.

Question 5

Do you receive dividends on a Moderna CFD?

Accepted Answer

Moderna does not pay a cash dividend at this time. The company is reinvesting available cash into research and development as part of the path to operating break-even. If a dividend were ever initiated, LHFX would apply an adjustment on the ex-dividend date so that long positions receive the equivalent credit and short positions are debited, mirroring the economic impact of the cash payment on the underlying share.

Question 6

Can a CFD trader go short on MRNA, and how does that compare with shorting the share?

Accepted Answer

Yes. A sell-side MRNA CFD has the same 1:20 leverage cap, the same $3 per side commission and the same overnight swap mechanics as a buy-side CFD. Shorting via a US brokerage account requires a margin agreement, an available borrow on the underlying share, and a stock-borrow fee that varies with demand. The CFD short is symmetrical with the long, which is one reason CFD products attract traders who want to position around clinical-readout risk without the operational friction of stock-borrow arrangements.

compare.col.product	compare.col.minimum	compare.col.leverage	compare.col.shorting	compare.col.cost
compare.cfd.label	compare.cfd.minimum	compare.cfd.leverage	compare.cfd.shorting	compare.cfd.cost
compare.share.label	compare.share.minimum	compare.share.leverage	compare.share.shorting	compare.share.cost
compare.etf.label	compare.etf.minimum	compare.etf.leverage	compare.etf.shorting	compare.etf.cost

hero.h1-prefix hero.h1-suffix?

tldr.heading

company.heading

model.heading

earnings.heading

earnings.example-heading

drivers.heading

drivers.covid-base-rate.title

drivers.phase3-readouts.title

drivers.rsv-and-combo.title

drivers.cash-runway.title

drivers.regulatory-policy.title

drivers.competitive-readouts.title

sessions.heading

compare.heading

cfd-vs-share.heading

at-lhfx.heading

at-lhfx.example-heading

risks.heading

risks.platform-concentration.title

risks.cash-pipeline-race.title

risks.regulatory-whiplash.title

risks.leverage-amplification.title

Frequently Asked Questions

Open an MRNA position from $10